Table 2 Background clinical data and characteristics of each group
From: Modified A-DROP score and mortality in hemodialysis patients with pneumonia
| Severity of pneumonia | Modified | Modified | Modified | ||||
|---|---|---|---|---|---|---|---|
| A-DROP | A-DROP | A-DROP | |||||
| 0, 1 | 2 | 3, 4 | |||||
| n = 27 | n = 22 | n = 15 | p value | ||||
| Age (years) | 65 | 37–81 | 76 | 59–88 | 81 | 74–88 | <0.001*** |
| Male (n, %) | 16 | 59.3 | 19 | 86.4 | 12 | 80.0 | 0.09 |
| BMI (kg/m2) | 20.7 | 16.1–40.9 | 19.4 | 14.3–26.3 | 20.4 | 14.8–23.9 | 0.66 |
| Duration of HD (months) | 47 | 3–231 | 37 | 2–290 | 48 | 1–154 | 0.97 |
| Cause of HD | |||||||
| DMN (n, %) | 8 | 29.7 | 12 | 54.6 | 7 | 46.7 | 0.20 |
| Chronic GN (n, %) | 10 | 37.0 | 6 | 27.3 | 5 | 33.3 | 0.75 |
| Nephrosclerosis (n, %) | 5 | 18.5 | 2 | 9.1 | 3 | 20.0 | 0.62 |
| RPGN (n, %) | 3 | 11.1 | 1 | 4.5 | 0 | 0 | 0.54 |
| Other (n, %) | 1 | 3.7 | 1 | 4.5 | 0 | 0 | 1.00 |
| Vascular access | |||||||
| AVF (n, %) | 21 | 77.8 | 13 | 59.1 | 8 | 53.3 | 0.21 |
| AVG (n, %) | 3 | 11.1 | 8 | 36.4 | 4 | 26.7 | 0.10 |
| Catheter (n, %) | 3 | 11.1 | 1 | 4.5 | 3 | 20.0 | 0.40 |
| Comorbidity | |||||||
| CVD (n, %) | 13 | 48.1 | 10 | 45.5 | 11 | 73.3 | 0.23 |
| Malignancy (n, %) | 4 | 14.8 | 4 | 18.2 | 4 | 26.7 | 0.65 |
| CLD (n, %) | 6 | 22.2 | 5 | 22.7 | 2 | 13.3 | 0.85 |
| Vital signs | |||||||
| Systolic BP (mmHg) | 129 | 88–204 | 150 | 97–170 | 120 | 68–203 | 0.18 |
| Diastolic BP (mmHg) | 74 | 53–103 | 72 | 47–141 | 64 | 40–99 | 0.24 |
| Heart rate (/min) | 98 | 68–142 | 96 | 68–136 | 94 | 58–130 | 0.49 |
| Altered mentality (n, %) | 0 | 0 | 7 | 31.8 | 14 | 93.3 | <0.001*** |
| Fever (degree) | 37.1 | 35.5–39.6 | 37.7 | 35.0–39.3 | 37.8 | 36.1–39.3 | 0.38 |
| Hypoxia (n, %) | 11 | 40.7 | 19 | 86.4 | 15 | 100 | <0.001*** |
| Blood examination | |||||||
| Alb (g/dL) | 3.1 | 2.1–4.1 | 3.3 | 2.1–4.3 | 3.0 | 2.0–3.9 | 0.39 |
| BUN (mg/dL) | 35.2 | 13.2–80.7 | 39.4 | 12.9–84.5 | 34.2 | 13.6–74.3 | 0.48 |
| Cr (mg/dL) | 5.99 | 1.48–13.32 | 5.23 | 2.10–13.05 | 5.25 | 2.65–11.20 | 0.26 |
| Na (mEq/L) | 138 | 129–145 | 140 | 132–147 | 140 | 131–147 | 0.11 |
| K (mEq/L) | 4.2 | 3.2-5.9 | 4.5 | 3.5–8.2 | 4.1 | 2.9–8.4 | 0.25 |
| CRP (mg/dL) | 7.91 | 1.21–30.80 | 9.16 | 0.85–43.12 | 9.54 | 1.37–13.99 | 0.98 |
| WBC (/μL) | 9600 | 4220–23100 | 9910 | 3130–33520 | 9580 | 3600–28910 | 0.99 |
| Hb (g/dL) | 10.6 | 4.1–16.5 | 10.9 | 7.6–14.4 | 10.5 | 7.1–13.5 | 0.98 |
| Plt (x 104/μL) | 16.2 | 2.7–50.0 | 17.6 | 2.1–31.3 | 14.4 | 6.8–72.0 | 0.88 |
| Bacterial cultures | |||||||
| Sputum (n, %) | 20 | 74.1 | 20 | 90.9 | 14 | 93.3 | 0.22 |
| Blood (n, %) | 17 | 63.0 | 20 | 90.9 | 10 | 66.7 | 0.07 |
| Radiological findings | |||||||
| Multi-lobar lesion (n, %) | 15 | 55.6 | 15 | 68.2 | 12 | 80.0 | 0.26 |
| Pleural effusion (n, %) | 14 | 51.9 | 15 | 68.2 | 14 | 93.3 | 0.012* |
| Therapy and prognosis | |||||||
| Success of initial therapy | |||||||
| (n, %) | 21 | 77.8 | 17 | 77.3 | 8 | 53.3 | 0.22 |
| Duration of antibiotics | |||||||
| (days) | 8 | 1–43 | 12 | 3–36 | 13 | 3–36 | 0.023* |
| 30-day mortality (n, %) | 1 | 3.7 | 2 | 9.1 | 6 | 40.0 | 0.004** |
| Hospital mortality (n, %) | 1 | 3.7 | 3 | 13.6 | 7 | 46.7 | 0.003** |